Mattress momentum to sustain; margins hold key to print
After a 78% PAT surge in FY26, the mattress segment's growth curve enters Q1. Watch margin resilience and whether consumer demand holds post-festival season lull.
The Setup
Sheela Foam enters Q1 FY27 on the back of a transformational FY26: consolidated PAT surged 78% YoY to ₹161 Cr, revenue grew 11%, and the mattress segment emerged as the growth spine—logging double-digit growth through the year. The composite merger with Kurlon Enterprise Limited (completed Apr 2026) added footprint but also integration drag; Q1 will be the first full quarter of blended operations. Price momentum is bullish (₹790.6, +73% off the 52-week low, above all key moving averages), but FII ownership has softened to 4.15% (from 6.2% a year ago). This print will test whether the mattress surge can sustain Q1's tougher seasonality and whether margins hold.
What to Expect
~₹350–380 Cr
In line with Q4 momentum (₹360 Cr run-rate) and mattress growth trajectory; absorbs summer season volatility
~₹35–42 Cr
Margin recovery in FY26 normalized to 10–11% range; watch for operating leverage and merger costs
Double-digit %
Segment has been the growth lever; expect steady momentum but Q1 faces post-holiday demand normalization
~16–17%
Recovery intact from COVID lows; watch commodity costs and input inflation
A strong print would show mattress volumes sustaining double-digit growth, EBITDA margin staying above 16%, and consolidated revenue tracking the ₹360–370 Cr zone (Q4 level or higher) despite Q1 seasonality. Merger-related expenses should show up clearly; if they compress below expectations, operating leverage improves the narrative. A weak print would flag mattress growth cooling to mid-single digits, margin compression below 15% (signaling input cost pressures or mix headwind), or revenue miss the ₹340 Cr floor due to demand softness post-festival season. Any guidance walk or commentary on FY27 full-year trajectory will carry weight given the strong FY26 base.
On Track?
Yes, but with caveats. FY26 saw ₹161 Cr PAT on ₹1,447 Cr revenue (11.1% net margin)—a recovery from prior-year challenges. The Q4 FY26 sprint (revenue +24% QoQ, PAT +78% YoY) was buoyed by pent-up mattress demand and margin normalization post-COVID pricing pressures. Q1 entering a calendar trough (summer, post-wedding season, school holidays = lower discretionary spend) and integrating a sizable acquisition (Kurlon) means management's forward guidance and tone on FY27 targets will matter as much as the headline numbers. If mattress growth persists and margins hold above 10%, the full-year trajectory remains intact.
Street View
Since Last Quarter
1 · Kurlon Merger Complete (Apr 2026)
4.88M new shares listed post-amalgamation; fractional share compensation (₹3.07L) paid in May. Integration ongoing; Q1 will show first blended quarter. Watch management guidance on synergies, cost rationalization, and overlap resolution.
2 · Board Reconstitution (May–Jun 2026)
Three independent directors (Som Mittal, Ravindra Dhariwal, Anil Tandon) completed second term (Jun 6); new IDs appointed including Neeraj Jain (CA, Company Secretary). Routine governance refresh; no material red flags.
3 · FY26 Final Dividend & Shareholder Distribution (Jun 2026)
Board approved ₹1/share (20% on ₹5 FV) for FY26; record date Jul 9, paid post-AGM (Jul 16). Signals confidence in cash generation; consistent with prior years.
4 · Updated Annual Report—Mattress Volume Highlight (Jul 13)
Sheela Foam updated FY26 Annual Report to explicitly call out mattress volume growth in the Corporate Overview. Signals management's emphasis on this segment as the growth narrative post-Kurlon. Watch for this momentum quantification in Q1.
5 · Trading Window Closure (Jun 30)
Routine pre-result window closure per SEBI Insider Trading Regulations. No insider activity signaled.
Three Things to Watch
1. Mattress segment metrics & growth rate: Management will likely detail segment revenues and volumes in the result commentary. A print showing mattress double-digit growth holds the bull thesis. Any deceleration below 8% invites questions about demand shift or competitive pressure. 2. Margin bridge & Kurlon synergies: Expect the board to discuss integration progress, overlapping costs (manufacturing, sales force, distribution), and what hit (or upside) Q1 took. A credible roadmap to ₹50 Cr+ annual synergies would reassure the market; vague commentary raises integration risk. 3. FY27 guidance & consumer durables outlook: Post-strong FY26, management's tone on full-year growth (revenue CAGR, margin sustainability) and macroeconomic headwinds (input inflation, credit tightness, rural consumption) will anchor the market's FY27 modeling.
Sheela Foam's Q1 print lands at an inflection: can mattress-led growth sustain past the summer trough and post-merger churn? The stock's +73% gain off the low and bullish price action suggest the market is already pricing a credible narrative. A beat on mattress volumes, steady margin hold, and clear Kurlon synergy roadmap will validate the bull case. A miss on any of these—or weakened FY27 guidance—risks a sharp repricing. The 3% dividend yield and value positioning offer downside support, but momentum traders will focus on execution. Watch the mattress segment grow-rate and management's confidence in FY27 full-year targets.
Informational and educational content only. Not investment advice.